Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
drug5097 | nonfood-specific go/no-go computerized training Wiki | 1.00 |
Navigate: Correlations HPO
There is one clinical trial.
The purpose of this study is to assess the effect of a food-specific Go/No-Go (GNG) computerized training task on weight loss, food evaluation, and disinhibition in a population of overweight and obese individuals.
Description: Body weight will be measured by participant using personal or university scale. Participants will take a picture of their weight send it to the research team (Due to COVID-19 precautions, in person weighing is not possible).
Measure: Change in body weight from baseline to post 4-week intervention, to 6-month follow-up Time: baseline, post 4-week intervention, 6-month follow-upDescription: This will be measured using the Disinhibition subscale of the Three Factor Eating Questionnaire; minimum value = 0; maximum value = 16; higher scores for this measure means worse outcomes
Measure: Change in disinhibition scores from baseline to post 4-week intervention, to 6-month follow-up. Time: baseline, post 4-week intervention, 6-month follow-upDescription: This will be measured using a food frequency questionnaire assessing food intake over the previous month.
Measure: Change in frequency of food consumption from baseline to post 4-week intervention, to 6-month follow-up. Time: baseline, post 4-week intervention, 6-month follow-upDescription: This will be measured using the binge eating questions of the Eating Disorder Examination Questionnaire; minimum value = 0; maximum value = unlimited; higher scores for this measure means worse outcomes
Measure: Change in binge eating behaviors from baseline to post 4-week intervention, to 6-month follow-up. Time: baseline, post 4-week intervention, 6-month follow-upDescription: This will be measured using a visual analog scale; minimum value = -100; maximum value = 100; higher scores for this measure on healthy foods means better outcomes, higher scores on this measure for unhealthy foods means worse outcomes
Measure: Change in liking of foods from baseline to post 4-week intervention, to 6-month Time: baseline, post 4-week intervention, 6-month follow-upDescription: This will be measured using an impulsive food choice test.
Measure: Change in automatic responses to healthy and unhealthy foods from baseline to post 4-week intervention, to 6-month Time: baseline, post 4-week intervention, 6-month follow-upAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports